Ron Cohen - Mar 31, 2023 Form 4 Insider Report for Acorda Therapeutics, Inc. (ACOR)

Role
President and CEO, Director
Signature
/s/ Ron Cohen
Stock symbol
ACOR
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 04:42 PM
Previous filing
Mar 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Employee Stock Option (right to buy) Award $0 +169K $0.00 169K Mar 31, 2023 Common Stock 169K $0.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to the options vest in equal quarterly installments over two years beginning on January 1, 2023 with the first quarterly installment vesting on April 1, 2023.